Oracle Corporation $ORCL Shares Sold by Endowment Wealth Management Inc.

Endowment Wealth Management Inc. trimmed its position in Oracle Corporation (NYSE:ORCL) by 5.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,132 shares of the enterprise software provider’s stock after selling 123 shares during the quarter. Endowment Wealth Management Inc.’s holdings in Oracle were worth $466,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in ORCL. Nuveen LLC acquired a new position in shares of Oracle in the 1st quarter worth approximately $732,692,000. Vanguard Group Inc. lifted its holdings in Oracle by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock worth $22,498,982,000 after buying an additional 3,513,464 shares in the last quarter. Kingstone Capital Partners Texas LLC acquired a new stake in Oracle during the 2nd quarter worth approximately $731,512,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Oracle by 79.2% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider’s stock worth $648,572,000 after buying an additional 2,049,687 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its holdings in Oracle by 840.7% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider’s stock worth $463,380,000 after buying an additional 1,894,157 shares in the last quarter. 42.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Oracle

In related news, insider Michael D. Sicilia sold 33,845 shares of the stock in a transaction on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the sale, the insider owned 132,656 shares in the company, valued at $42,603,800.96. This represents a 20.33% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William G. Parrett sold 11,500 shares of the firm’s stock in a transaction on Friday, September 12th. The stock was sold at an average price of $306.00, for a total transaction of $3,519,000.00. Following the completion of the sale, the director owned 17,764 shares of the company’s stock, valued at $5,435,784. This trade represents a 39.30% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 104,314 shares of company stock worth $31,272,223 in the last quarter. 40.90% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ORCL. Robert W. Baird began coverage on shares of Oracle in a report on Wednesday. They set an “outperform” rating and a $365.00 target price on the stock. Scotiabank reiterated an “outperform” rating on shares of Oracle in a report on Wednesday, September 10th. Morgan Stanley increased their target price on shares of Oracle from $246.00 to $320.00 and gave the stock an “equal weight” rating in a report on Tuesday, September 23rd. Cantor Fitzgerald increased their target price on shares of Oracle from $271.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, September 10th. Finally, JPMorgan Chase & Co. increased their target price on shares of Oracle from $185.00 to $210.00 and gave the stock a “neutral” rating in a report on Monday, September 8th. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $306.71.

Oracle Trading Down 1.3%

NYSE ORCL opened at $293.04 on Monday. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. The firm’s fifty day moving average price is $266.69 and its 200 day moving average price is $210.74. The company has a market capitalization of $835.40 billion, a price-to-earnings ratio of 67.83, a price-to-earnings-growth ratio of 3.15 and a beta of 1.53. Oracle Corporation has a 12 month low of $118.86 and a 12 month high of $345.72.

Oracle (NYSE:ORCL) last posted its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The company had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The company’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period last year, the business earned $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, sell-side analysts expect that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be paid a dividend of $0.50 per share. The ex-dividend date is Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 0.7%. Oracle’s dividend payout ratio is currently 46.30%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.